Insider · CIK 0001305975
David F Hoffmeister
director
Files at ICUI (ICU MEDICAL INC/DE), GKOS (GLAUKOS Corp), CE (Celanese Corp), STEP (StepStone Group Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | STEP StepStone Group Inc. | AGrant or award Class A Common Stock | +5,616 | $50.74 | $285k | 19,550 | 32 d ago |
| Jun 11, 2025 | GKOS GLAUKOS Corp | MOption exercise Common Stock | +25,000 | $32.00 | $800k | 31,918 | Jun 13, 2025 |
| Jun 11, 2025 | GKOS GLAUKOS Corp | MOption exercise Stock Option (Right to Buy)derivative | -25,000 | $0.00 | $0 | 0 | Jun 13, 2025 |
| Jan 2, 2025 | GKOS GLAUKOS Corp | AGrant or award Common Stock | +557 | $0.00 | $0 | 4,810 | Jun 2, 2025 |
| May 29, 2025 | GKOS GLAUKOS Corp | AGrant or award Common Stock | +2,108 | $0.00 | $0 | 6,918 | Jun 2, 2025 |
| May 29, 2025 | GKOS GLAUKOS Corp | AGrant or award Stock Option (Right to Buy)derivative | +3,149 | $94.87 | $299k | 3,149 | Jun 2, 2025 |
| May 13, 2025 | ICUI ICU MEDICAL INC/DE | MOption exercise Common Stock | +1,723 | $0.00 | $0 | 4,750 | May 13, 2025 |
| May 9, 2025 | CE Celanese Corp | AGrant or award Common Stock | +3,376 | $0.00 | $0 | 4,490 | May 13, 2025 |
| May 13, 2025 | ICUI ICU MEDICAL INC/DE | AGrant or award Common Stockderivative | +1,254 | $0.00 | $0 | 1,254 | May 13, 2025 |
| May 13, 2025 | ICUI ICU MEDICAL INC/DE | MOption exercise Common Stockderivative | -1,723 | $0.00 | $0 | 0 | May 13, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.